| Intrinsic Valuation of: MDLZ | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 2 | Market Cap | $78B | |||||
| 2021 | - | - (-) | P/E Ratio | 30 | Total Asset | $71B | |||||
| 2022 | $3B | - (-) | Net Income | $2B | Total Debt | $17B | |||||
| 2023 | $4B | 20.0% (4.9%) | EBITDA | $5B | Total Liab | $46B | |||||
| 2024 | $4B | -2.2% (-3.3%) | Opr Margin | 9.39 | Debt/Equity | 0.67 | |||||
| 2025 | $3B | -8.2% (-13.2%) | PreTax Margin | 7.84 | BV/Share | -14 | |||||
| 5Y Average FCF | $3B | 5.5% (-3.9%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.00% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (5.5%) | ||||||||||
| 2026 | $3B | MBG Intrinsic Value | $18 | ||||||||
| 2027 | $4B | ||||||||||
| 2028 | $4B | ||||||||||
| 2029 | $4B | ||||||||||
| 2030 | $4B | ||||||||||
| 2031 | $4B | ||||||||||
| Terminal Value | $94B | Net Worth/Share | $20 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $81B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $2B | $51 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $17B | WACC | 6.5% | 47 | 52 | 59 | 67 | 78 | |||
| Equity Value | $65B | 7.1% | 41 | 45 | 49 | 55 | 63 | ||||
| Shares Outstanding | 1,283,649,766 | 7.8% | 35 | 38 | 42 | 46 | 52 | ||||
| 8.4% | 31 | 33 | 36 | 40 | 44 | ||||||
| DCF Intrinsic Value | $51 | 9.0% | 27 | 29 | 32 | 34 | 37 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||